http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019031489-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2e61866e714198ee02a24037c9670828 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439 |
filingDate | 2018-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce89654d7017f9ad0bd3e3cebb55cc69 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91567311d7093c01da860bf703247ef0 |
publicationDate | 2019-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2019031489-A |
titleOfInvention | Tablets containing esomeprazole magnesium hydrate |
abstract | [PROBLEMS] To improve the stability of an active ingredient in a preparation. [MEANS FOR SOLVING PROBLEMS] The present invention improves the stability of an active ingredient in a preparation by adopting a specific substance as a component of the preparation. One embodiment of the present invention is a formulation (eg, a tablet) comprising sodium starch glycolate, low substituted hydroxypropyl cellulose or crospovidone as a specific disintegrant. The active ingredient of the preparation of the present invention includes a proton pump inhibitor (for example, esomeprazole), a salt thereof, or a hydrate thereof. [Selection figure] None |
priorityDate | 2017-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 43.